{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:23:34Z","timestamp":1793820214650,"version":"4.6.1"},"reference-count":47,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"unspecified","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2020,7,21]]},"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The immunological microenvironment of primary high-grade serous carcinomas (HGSCs) has a major impact on disease outcome. Conversely, little is known on the microenvironment of metastatic HGSCs and its potential influence on patient survival. Here, we explore the clinical relevance of the immunological configuration of HGSC metastases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>RNA sequencing was employed on 24 paired primary tumor microenvironment (P-TME) and metastatic tumor microenvironment (M-TME) chemotherapy-naive HGSC samples. Immunohistochemistry was used to evaluate infiltration by CD8<jats:sup>+<\/jats:sup> T cells, CD20<jats:sup>+<\/jats:sup> B cells, DC-LAMP<jats:sup>+<\/jats:sup> (lysosomal-associated membrane protein 3) dendritic cells (DCs), NKp46<jats:sup>+<\/jats:sup> (natural killer) cells and CD68<jats:sup>+<\/jats:sup>CD163<jats:sup>+<\/jats:sup> M2-like tumor-associated macrophages (TAMs), abundance of PD-1<jats:sup>+<\/jats:sup> (programmed cell death 1), LAG-3<jats:sup>+<\/jats:sup> (lymphocyte-activating gene 3) cells, and PD-L1 (programmed death ligand 1) expression in 80 samples. Flow cytometry was used for functional assessments on freshly resected HGSC samples.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>1468 genes were differentially expressed in the P-TME versus M-TME of HGSCs, the latter displaying signatures of extracellular matrix remodeling and immune infiltration. M-TME infiltration by immune effector cells had little impact on patient survival. Accordingly, M-TME-infiltrating T cells were functionally impaired, but not upon checkpoint activation. Conversely, cytokine signaling in favor of M2-like TAMs activity appeared to underlie inhibited immunity in the M-TME and poor disease outcome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Immunosuppressive M2-like TAM infiltrating metastatic sites limit clinically relevant immune responses against HGSCs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jitc-2020-000979","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T01:20:45Z","timestamp":1597972845000},"page":"e000979","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":99,"title":["M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer"],"prefix":"10.1136","volume":"8","author":[{"given":"Michal","family":"Hensler","sequence":"first","affiliation":[{"name":"Sotio, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Kasikova","sequence":"additional","affiliation":[{"name":"Sotio, Prague, Czech Republic"},{"name":"Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Fiser","sequence":"additional","affiliation":[{"name":"CLIP-Childhood Leukemia Investigation Prague, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University Prague and University Hospital Motol, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Rakova","sequence":"additional","affiliation":[{"name":"Sotio, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Skapa","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Laco","sequence":"additional","affiliation":[{"name":"The Fingerland Department of Pathology, Charles University, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Lanickova","sequence":"additional","affiliation":[{"name":"Sotio, Prague, Czech Republic"},{"name":"Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"Pecen","sequence":"additional","affiliation":[{"name":"Sotio, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Truxova","sequence":"additional","affiliation":[{"name":"Sotio, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarka","family":"Vosahlikova","sequence":"additional","affiliation":[{"name":"Sotio, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Moserova","sequence":"additional","affiliation":[{"name":"Sotio, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Praznovec","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Charles University, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vit","family":"Drochytek","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Charles University, 3rd Faculty of Medicine and University Hospital Kralovske Vinohrady, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rehackova","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Charles University, 3rd Faculty of Medicine and University Hospital Kralovske Vinohrady, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Brtnicky","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Rob","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Charles University, 3rd Faculty of Medicine and University Hospital Kralovske Vinohrady, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Benes","sequence":"additional","affiliation":[{"name":"Genomics Core Facility, EMBL, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Pistolic","sequence":"additional","affiliation":[{"name":"Genomics Core Facility, EMBL, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludek","family":"Sojka","sequence":"additional","affiliation":[{"name":"Sotio, Prague, Czech Republic"},{"name":"Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ales","family":"Ryska","sequence":"additional","affiliation":[{"name":"The Fingerland Department of Pathology, Charles University, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1735-8722","authenticated-orcid":false,"given":"Catherine","family":"Sautes-Fridman","sequence":"additional","affiliation":[{"name":"INSERM, U1138, Centre de Recherche des Cordeliers, Paris, France"},{"name":"Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf Herve","family":"Fridman","sequence":"additional","affiliation":[{"name":"INSERM, U1138, Centre de Recherche des Cordeliers, Paris, France"},{"name":"Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Galluzzi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Weill Cornell Medical College, New York City, New York, USA"},{"name":"Sandra and Edward Meyer Cancer Center, New York City, New York, USA"},{"name":"Caryl and Israel Englander Institute for Precision Medicine, New York City, New York, USA"},{"name":"Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA"},{"name":"Universit\u00e9 de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radek","family":"Spisek","sequence":"additional","affiliation":[{"name":"Sotio, Prague, Czech Republic"},{"name":"Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8423-479X","authenticated-orcid":false,"given":"Jitka","family":"Fucikova","sequence":"additional","affiliation":[{"name":"Sotio, Prague, Czech Republic"},{"name":"Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"key":"2025100301455634000_8.2.e000979.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.101"},{"key":"2025100301455634000_8.2.e000979.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"2025100301455634000_8.2.e000979.3","doi-asserted-by":"publisher","DOI":"10.1038\/nature21349"},{"key":"2025100301455634000_8.2.e000979.4","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.69"},{"key":"2025100301455634000_8.2.e000979.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.09.024"},{"key":"2025100301455634000_8.2.e000979.6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2926"},{"key":"2025100301455634000_8.2.e000979.7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3847"},{"key":"2025100301455634000_8.2.e000979.8","doi-asserted-by":"publisher","DOI":"10.1007\/s12307-012-0122-y"},{"key":"2025100301455634000_8.2.e000979.9","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-15-0578"},{"key":"2025100301455634000_8.2.e000979.10","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.100105"},{"key":"2025100301455634000_8.2.e000979.11","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2492"},{"key":"2025100301455634000_8.2.e000979.12","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3394"},{"key":"2025100301455634000_8.2.e000979.13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-4175"},{"key":"2025100301455634000_8.2.e000979.14","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0781-z"},{"key":"2025100301455634000_8.2.e000979.15","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.99"},{"key":"2025100301455634000_8.2.e000979.16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","article-title":"Macrophages and metabolism in the tumor microenvironment","volume":"30","author":"Vitale","year":"2019","journal-title":"Cell Metab"},{"key":"2025100301455634000_8.2.e000979.17","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.169"},{"key":"2025100301455634000_8.2.e000979.18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00404-016-4035-8","article-title":"The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications","volume":"293","author":"Meinhold-Heerlein","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"2025100301455634000_8.2.e000979.19","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1470-2045(17)30438-2","article-title":"The TNM classification of malignant tumours-towards common understanding and reasonable expectations","volume":"18","author":"O'Sullivan","year":"2017","journal-title":"Lancet Oncol"},{"key":"2025100301455634000_8.2.e000979.20","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0446-3"},{"key":"2025100301455634000_8.2.e000979.21","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-1342"},{"key":"2025100301455634000_8.2.e000979.22","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0299"},{"key":"2025100301455634000_8.2.e000979.23","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw313"},{"key":"2025100301455634000_8.2.e000979.24","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118"},{"key":"2025100301455634000_8.2.e000979.25","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0620-6"},{"key":"2025100301455634000_8.2.e000979.26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006412"},{"key":"2025100301455634000_8.2.e000979.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020177"},{"key":"2025100301455634000_8.2.e000979.28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat7807","article-title":"The hallmarks of successful anticancer immunotherapy","volume":"10","author":"Galluzzi","year":"2018","journal-title":"Sci Transl Med"},{"key":"2025100301455634000_8.2.e000979.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.12.033"},{"key":"2025100301455634000_8.2.e000979.30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pharmthera.2019.04.004","article-title":"Stress responses in stromal cells and tumor homeostasis","volume":"200","author":"Vitale","year":"2019","journal-title":"Pharmacol Ther"},{"key":"2025100301455634000_8.2.e000979.31","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21456"},{"key":"2025100301455634000_8.2.e000979.32","doi-asserted-by":"publisher","DOI":"10.4161\/onci.22009"},{"key":"2025100301455634000_8.2.e000979.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2009.11.020"},{"key":"2025100301455634000_8.2.e000979.34","doi-asserted-by":"publisher","DOI":"10.1038\/nm1093"},{"key":"2025100301455634000_8.2.e000979.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2011.09.039"},{"key":"2025100301455634000_8.2.e000979.36","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0234"},{"key":"2025100301455634000_8.2.e000979.37","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-6595"},{"key":"2025100301455634000_8.2.e000979.38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009615"},{"key":"2025100301455634000_8.2.e000979.39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001323"},{"key":"2025100301455634000_8.2.e000979.40","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxw020"},{"key":"2025100301455634000_8.2.e000979.41","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4375"},{"key":"2025100301455634000_8.2.e000979.42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI87252"},{"key":"2025100301455634000_8.2.e000979.43","first-page":"5857","article-title":"Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression","volume":"60","author":"Shimura","year":"2000","journal-title":"Cancer Res"},{"key":"2025100301455634000_8.2.e000979.44","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-306"},{"key":"2025100301455634000_8.2.e000979.45","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12096"},{"key":"2025100301455634000_8.2.e000979.46","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00262-019-02429-2","article-title":"Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response","volume":"68","author":"Qi","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"2025100301455634000_8.2.e000979.47","doi-asserted-by":"crossref","unstructured":"Galluzzi L , Humeau J , Buqu\u00e9 A , et al . Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nat Rev Clin Oncol. In Press 2020;136.doi:10.1038\/s41571-020-0413-z","DOI":"10.1038\/s41571-020-0413-z"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2020-000979","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T08:46:06Z","timestamp":1759481166000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2020-000979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,8,20]]},"published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1136\/jitc-2020-000979"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2020-000979","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}